SUI Group director awarded warrant grants

SUI Group Holdings Ltd. reported a new equity award to director Brian David Quintenz.

Accepted by SEC EDGAR 01/15/2026 - 11:59 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

SUI Group Holdings Ltd. reported a new equity award to director Brian David Quintenz. On January 5, 2026, he received four tranches of warrants for common stock as a one-time equity grant for his non-management director compensation upon his appointment to the board. The tranches cover 83,026 warrants at an exercise price of $5.42, and three additional tranches of 41,513 warrants each with exercise prices of $5.962, $6.504, and $7.046, all granted at a price of $0 to the director. According to the vesting schedule, 25% of each tranche becomes exercisable on July 5, 2026, then 25% on January 5, 2027, another 25% on July 5, 2027, and the final 25% on January 5, 2028, with all warrants expiring on January 5, 2031.

Insider Trade Summary

Grant/Award: 207,565 shares

Grant/Award 4 txns

Insider Quintenz Brian David

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Warrant for Common Stock	83,026	$0.00	$0.00
Grant/Award	Warrant for Common Stock	41,513	$0.00	$0.00
Grant/Award	Warrant for Common Stock	41,513	$0.00	$0.00
Grant/Award	Warrant for Common Stock	41,513	$0.00	$0.00

Holdings After Transaction: Warrant for Common Stock — 207,565 contracts (Direct)

Footnotes (2)

1. F1. Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026.
2. F2. The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 4 filing for MCVT/SUI Group report?

It reports that director Brian David Quintenz received a one-time equity grant of warrants for common stock from SUI Group Holdings Ltd. as part of his non-management director compensation effective January 5, 2026.

How many warrants did the SUI Group (MCVT) director receive and at what prices?

The director received 83,026 warrants with a $5.42 exercise price and three additional tranches of 41,513 warrants each, with exercise prices of $5.962, $6.504, and $7.046, all granted at a price of $0 to him.

What is the vesting schedule for the SUI Group director’s warrants?

The warrants vest in four equal parts: 25% of each tranche becomes exercisable on July 5, 2026, another 25% on January 5, 2027, another 25% on July 5, 2027, and the final 25% on January 5, 2028.

When do the warrants reported in this MCVT Form 4 expire?

All of the director’s warrants reported in this filing have an expiration date of January 5, 2031.

Is this SUI Group (MCVT) Form 4 an open-market purchase or a compensatory grant?

This is a compensatory grant. The footnotes state it is a one-time equity grant as part of the director’s non-management compensation upon his appointment to the board, and the warrants were granted at $0 to him.

Does Brian Quintenz hold these SUI Group warrants directly or indirectly?

The filing lists the ownership of all reported warrants as Direct (D) by Brian David Quintenz, with no indirect ownership entity noted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Quintenz Brian David

(Last) (First) (Middle)

C/O SUI GROUP HOLDINGS LIMITED

1907 WAYZATA BOULEVARD, SUITE 205

(Street)

WAYZATA MN 55391

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SUI Group Holdings Ltd. [ SUIG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant for Common Stock	$5.42	01/05/2026		A		83,026(1)		(2)	01/05/2031	Common Stock	83,026	$0	83,026	D
Warrant for Common Stock	$5.962	01/05/2026		A		41,513(1)		(2)	01/05/2031	Common Stock	41,513	$0	41,513	D
Warrant for Common Stock	$6.504	01/05/2026		A		41,513(1)		(2)	01/05/2031	Common Stock	41,513	$0	41,513	D
Warrant for Common Stock	$7.046	01/05/2026		A		41,513(1)		(2)	01/05/2031	Common Stock	41,513	$0	41,513	D

Explanation of Responses:

1. Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026.

2. The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028.

	/s/ Brian Quintenz	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.